These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7086846)

  • 1. Use of a potential rabbit model for structure--behavioral activity studies of cannabinoids.
    Consroe P; Martin AR; Fish BS
    J Med Chem; 1982 May; 25(5):596-9. PubMed ID: 7086846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabbit behavioral model of marijuana psychoactivity in humans.
    Consroe P; Fish BS
    Med Hypotheses; 1981 Aug; 7(8):1079-90. PubMed ID: 6270517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids. I. Behavioral effects.
    Stark P; Dews PB
    J Pharmacol Exp Ther; 1980 Jul; 214(1):124-30. PubMed ID: 6771386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models to predict cannabinoid-induced disturbances.
    Edery H
    Arch Toxicol Suppl; 1983; 6():91-103. PubMed ID: 6578751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of indole- and pyrrole-derived cannabinoids.
    Wiley JL; Compton DR; Dai D; Lainton JA; Phillips M; Huffman JW; Martin BR
    J Pharmacol Exp Ther; 1998 Jun; 285(3):995-1004. PubMed ID: 9618400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cannabinoid with cardiovascular activity but no overt behavioral effects.
    Adams MD; Earnhardt JT; Martin BR; Harris LS; Dewey WL; Razdan RK
    Experientia; 1977 Sep; 33(9):1204-5. PubMed ID: 891878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ontogeny of delta-9-tetrahydrocannabinol responsiveness in the rabbit.
    Fish BS; Consroe P
    Dev Psychobiol; 1983 Mar; 16(2):147-58. PubMed ID: 6299864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological evaluation of agonistic and antagonistic activity of cannabinoids.
    Martin BR; Compton DR; Little PJ; Martin TJ; Beardsley PM
    NIDA Res Monogr; 1987; 79():108-22. PubMed ID: 2830532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis: pharmacology and toxicology in animals and humans.
    Adams IB; Martin BR
    Addiction; 1996 Nov; 91(11):1585-614. PubMed ID: 8972919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of delta 9-tetrahydrocannabinol and other cannabinoids on cAMP accumulation in synaptosomes.
    Little PJ; Martin BR
    Life Sci; 1991; 48(12):1133-41. PubMed ID: 1848340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.
    Tanda G; Goldberg SR
    Psychopharmacology (Berl); 2003 Sep; 169(2):115-34. PubMed ID: 12827346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea.
    Parker LA; Mechoulam R; Schlievert C; Abbott L; Fudge ML; Burton P
    Psychopharmacology (Berl); 2003 Mar; 166(2):156-62. PubMed ID: 12528012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol.
    Beardsley PM; Scimeca JA; Martin BR
    J Pharmacol Exp Ther; 1987 May; 241(2):521-6. PubMed ID: 3033218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral suppression induced by cannabinoids is due to activation of the arachidonic acid cascade in rats.
    Yamaguchi T; Shoyama Y; Watanabe S; Yamamoto T
    Brain Res; 2001 Jan; 889(1-2):149-54. PubMed ID: 11166698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantiomeric cannabinoids: stereospecificity of psychotropic activity.
    Mechoulam R; Feigenbaum JJ; Lander N; Segal M; Järbe TU; Hiltunen AJ; Consroe P
    Experientia; 1988 Sep; 44(9):762-4. PubMed ID: 3416993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some 9-hydroxycannabinoid-like compounds. Synthesis and evaluation of analgesic and behavioral properties.
    Wilson RS; May EL; Dewey WL
    J Med Chem; 1979 Jul; 22(7):886-8. PubMed ID: 448688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Δ
    Gatch MB; Forster MJ
    Psychopharmacology (Berl); 2018 Mar; 235(3):673-680. PubMed ID: 29138877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereochemical requirements for cannabinoid activity.
    Mechoulam R; Lander N; Varkony TH; Kimmel I; Becker O; Ben-Zvi Z; Edery H; Porath G
    J Med Chem; 1980 Oct; 23(10):1068-72. PubMed ID: 7420350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Testing the pharmacological activity of some synthetic cannabinoids in mice (author's transl)].
    Ganz AJ; Waser PG
    Arzneimittelforschung; 1980; 30(3):471-7. PubMed ID: 7387758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.